Learn from Prof. Gary Lichtenstein

Orlando Health's Digestive Health Institute is pleased to invite you to the Florida Inflammatory Bowel Disease Congress at the Gaylord Palms Resort & Convention Center in beautiful Central Florida.

Learn from Prof. Gary R. Lichtenstein

How position small molecules in the IBD treatment algorithm

Click to Register

Course Director

Udayakumar Navaneethan, MD

Medical Director, Center for Inflammatory Bowel Disease

Orlando Health Digestive Health Institute

Professor of Medicine

University of Central Florida College of Medicine

Guest Faculty

Anita Afzali, MD

Professor of Medicine

Executive Vice Chair

Dept. of Internal Medicine

University of Cincinnati College of Medicine

Cincinnati, OH

Jean Ashburn, MD

Assistant Professor of Surgery

Division of Colon and Rectal surgery

Atrium Health Wake Forest Baptist Medical Center

Winston-Salem, NC

Marla Dubinsky, MD

Chief of Pediatric Gastroenterology and Nutrition

Co-Director, The Susan and Leonard Feinstein Inflammatory Bowel Disease Center

Professor of Pediatrics and Medicine

Icahn School of Medicine at Mount Sinai Hospital

New York, NY

Stephen B. Hanauer, MD

Clifford Joseph Barborka Professor of Medicine

Medical Director of the Digestive Health Center

Northwestern University

Chicago, IL

Marietta Iacucci, MD PhD, FASGE

Associate Profess and Honorary

Gastroenterology Consultant

University Hospital

Birmingham, United Kingdom

Gary R. Lichtenstein, MD

Professor of Medicine

Division of Gastroenterology and Hepatology

Director, Cener for Inflammatory Bowel Disease

Raymond and Ruth Perelman School of Medicine

University of Pennsylvania

Philadelphia, PA

Miguel Regueiro, MD

Professor of Medicine

Chair, Digestive Disease and Surgery Institute

The Pier C. and Renne A. Borra Family Endowed Chair in Gastroenterology and Hepatology

Cleveland Clinic

Cleveland, OH

Bo Shen, MD

The Elderman-Jarislowsky Professor of Surgical Sciences

Professor of Medicine and Surgical Sciences (in Surgery)

Director, Inflammatory Bowel Disease Center

Columbia University Vagelos College of Physicians and Surgeons

New York, NY

Henit Yanai, MD

Head of IBD Center, Division of Gastroenterology Rabin Medical Center

Petah Tikva, Israel

AGENDA

REGISTRATION AND CONTINENTAL BREAKFAST

MEDICAL MANAGEMENT OF INFLAMMATORY BOWEL DISEASE (IBD)

Anti-TNFs should still be first line biologic in the Management of Moderate to Severe Inflammatory Bowel Disease

Dr. Stephen Hanauer

Non-anti-TNFs should be first line biologic in the Management

of Moderate to Severe Inflammatory Bowel Disease

Dr. Marla Dubinsky

Optimizing the use of anti-interleukins and anti-integrins in the Management of Inflammatory Bowel Disease

Miguel Regueiro, MD

Positioning small molecules in the Inflammatory Bowel Disease treatment algorithm

Gary Lichtenstein. MD

Video Case presentations and panel discussion: Choosing treatment options for moderate to severe ulcerative colitis and Crohn’s disease- Bi-naïve and Bio-failure

DEBATES IN IBD

Acute Severe Ulcerative Colitis Corticosteroids, Anti-TNFs and cyclosporine is the way to go

Gary Lichtenstein, MD

Colectomy is the way to go

Jean Ashburn, MD

Cancer Surveillance in IBD: High-definition while light endoscopy with random biopsies should be the opening move

Anita Afzali, MD

Chromoendoscopy and AI is the way to go

Marietta Iacucci, MD

Strictures in Crohn’s disease: Endoscopy should be the opening move

Udayakumar Navaneethan, MD

Get the knives out-Surgery is the way to go

Jean Ashburn, MD

Peri-anal Crohn’s disease: Medications and Endoscopy should be the opening move

Bo Shen, MD

Get the knives and setons out

Jean Ashburn, MD

Video Case presentations and panel discussion-Interventional IBD and colo-rectal surgery

MANAGEMENT OF IBD IN SPECIAL SITUATIONS

Management of IBD in women: Preconception to Peripartum Management of Patients with IBD

Henit Yanai, MD

Management of IBD in Children: Challenges and Opportunities

Marla Dubinsky, MD

Management of pouchitis and CD of the pouch

Bo Shen, MD

Therapeutic drug monitoring in clinical practice

Miguel Regueiro, MD

Diet and IBD

Henit Yanai, MD

Video Case presentations and panel discussion

CHALLENGES IN IBD MANAGEMENT AND THE FUTURE

State of the Art: How will I manage IBD in 2025- Predicting the crystalball

Stephen Hanauer, MD

State of the Art: “Personalized medicine in IBD” and integration of personalized medicine in the IBD treatment algorithm

Marla Dubinsky, MD

QUESTIONS, PANEL DISCUSSION AND CONCLUDING REMARKS

Click to Register

Book Hotel